Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is aim to study the changes of serum creatinine levels at 72 hours after admission in patients with acute heart failure who has diuretic resistance compared to those who do not have diuretic resistance from furosemide stress test
This study is an observational prospective study to demonstrate a prognosis of acute heart failure patients who have diuretic resistance compared to those who do not have diuretic resistance from furosemide stress test. The primary outcome is changes of serum creatinine levels at 72 hours compared to baseline values at the time of admission.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Heart failure with diuretic resistance | This group includes acute heart failure patients who has diuretic resistance from furosemide stress test. Furosemide stress test will be performed by administration of intravenous furosemide 1 mg/kg in patients who do not receive oral furosemide before and 1.5 mg/kg patients who have received oral furosemide before. Diuretic resistance was defined as urine output <250 hr at 2 hours after furosemide administration. |
| |
| Heart failure without diuretic resistance | This group includes acute heart failure patients who do not have diuretic resistance from furosemide stress test. Furosemide stress test will be performed by administration of intravenous furosemide 1 mg/kg in patients who do not receive oral furosemide before and 1.5 mg/kg patients who have never received oral furosemide before. Patients will be defined not to have diuretic resistance if their urine output ≥250 hr at 2 hours after furosemide administration. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Furosemide stress test | Diagnostic Test | Furosemide stress test is performed by administration of intravenous furosemide 1 mg/kg in patients who do not receive oral furosemide before and 1.5 mg/kg patients who have never received oral furosemide. |
| Measure | Description | Time Frame |
|---|---|---|
| Serum creatinine | Changes in serum creatinine from baseline | Seventy-two hours after admission |
| Measure | Description | Time Frame |
|---|---|---|
| Serum creatinine | Changes in serum creatinine from baseline | Day 7 of hospital admission |
| Requirement for renal replacement therapy | Renal replacement therapy is defined as any mode of dialysis or extracorporeal therapy to treat volume overload for heart failure |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with acute heart failure who require intravenous furosemide for the treatment of lung congestion
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Kajohnsak Noppakun, MD | Contact | +66815953465 | kajohnsak.noppakun@cmu.ac.th | |
| Tiranun Suriya, RN | Contact | +66818812106 | tingsuri@hotmail.co.th |
| Name | Affiliation | Role |
|---|---|---|
| Kajohnsak Noppakun, MD | Instructor, Division of Nephrology, Department of Internal Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chiang Mai University Hospital, Faculty of Medicine, Chiang Mai University | Recruiting | Chiang Mai | 50200 | Thailand |
Request for individual participant data (IPD) has to be submitted to the Institutional Review Board (IRB) of Faculty of Medicine, Chiang Mai University, Chiang Mai, THAILAND.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| D058186 | Acute Kidney Injury |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| During hospital admission period |
| Length of hospital admission | Numbers of days that patients need to stay in the hospital | During hospital admission period |
| Changes of the stage of heart failure defined by New York Heart Association (NYHA) classification | Heart failure stage defined by New York Heart Association (NYHA) classification | Day 7 and 28 after hospital admission |
| Numbers of hospital readmission | Readmission to the hospital due to heart failure | Month 1 and 3 after hospital discharge |
| Mortality rate | Confirmed death | Day 7 and 28 after hospital admission |
| D014570 |
| Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |